RankingsPricing
  1. US-listed companies
  2. AGIOS PHARMACEUTICALS, INC.
  3. Financials
  4. Accounts payable

AGIOS PHARMACEUTICALS, INC.AGIO

Market cap
$1.5B
P/E ratio
SummaryFinancials
Period EndAccounts payable (Million USD)YoY (%)
Dec 31, 202417+70.17%
Dec 31, 202310-47.46%
Dec 31, 202219+11.47%
Dec 31, 202117-37.79%
Dec 31, 202027+22.60%
Dec 31, 201922+22.46%
Dec 31, 201818-21.47%
Dec 31, 201723+33.09%
Dec 31, 201617+15.99%
Dec 31, 201515+33.26%
Dec 31, 201411+200.90%
Dec 31, 20134

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)